CLVS

Clovis Oncology Inc

Price:

0.08

USD

Volume:

24,516,460.00

United States | Biotechnology

-40,720.41 %

Upside

As of 2024-03-03, the Fair Value of Clovis Oncology Inc (CLVS) is -32.98 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 0.08 USD, the upside of Clovis Oncology Inc is -40,720.41%.

Note: valuation result may not be accurate due to the company's negative EPS.

0.08 USD

Stock Price

-32.98 USD

Fair Price

Peter Lynch's formula is:

CLVS Fair Value

= Earnings Growth Rate x TTM EPS
CLVS Fair Value

= 18.07 x -1.82
CLVS Fair Value

= -32.98
The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings | ||||||

2019-12-31 | 2020-12-31 | 2021-12-31 | - | - | 5Y Avg | |

Net income | -369.21 | -264.52 | - | - | -316.87 | |

YoY growth | 7.79% | 28.35% | - | - | 18.07% |

Market Cap (mil) | 11.77 |

P/E | |

Forward P/E |

EPS | -1.82 |

Avg earnings growth rate | 18.07% |

TTM earnings | -264.52 |